Fostemsavir tromethamine
Rukobia (fostemsavir tromethamine) is a small molecule pharmaceutical. Fostemsavir tromethamine was first approved as Rukobia on 2020-07-02. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Rukobia's patent is valid until 2027-11-19 (FDA).
| Trade Name | Rukobia |
|---|---|
| Common Name | Fostemsavir tromethamine |
| Indication | hiv infections |
| Drug Class | Antivirals; phosphoro-derivatives |
